11/14/2024
6:17 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
11/14/2024
3:53 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
3:32 PM | Alyeska Investment Group, L.P. (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
| Form SC 13G | |
11/13/2024
4:34 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/12/2024
5:32 AM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
6:02 AM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
12:00 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
2:45 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:17 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:02 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | Hollander David (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:15 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Parsons Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
2:16 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Strem Brian M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:47 PM | KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
2:40 PM | Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
6:02 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
2:43 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G | |
05/29/2024
2:47 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G | |
05/10/2024
5:59 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
11:15 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024
3:48 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 424B3 | |
03/25/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
6:03 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
6:00 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form PRE 14A | |
02/28/2024
3:40 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/14/2024
3:55 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lincoln Park Capital Fund, LLC (Filed by)
| Form SC 13G/A | |
Tesla Execs are Freaking Out (Ad) It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it.
And Elon Musk has completely restructured Tesla to chase this opportunity.
This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. |
02/13/2024
7:08 PM | KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
02/12/2024
4:23 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
8:22 AM | HIRSCHMAN ORIN (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
| Form SC 13G | |
02/06/2024
9:27 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/01/2024
6:01 AM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
4:14 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:16 PM | KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
